Literature DB >> 35022127

Sudden deterioration of CPAP adherence after myocardial infarction in a Chinese patient: potential effect of ACEI-induced airway hyperresponsiveness.

Yi-Hui Ou1, As Tar Thant1, Chi-Hang Lee1,2.   

Abstract

A patient with obstructive sleep apnea was admitted to the hospital with non-ST segment elevation myocardial infarction. An angiotensin-converting enzyme inhibitor was prescribed upon discharge. She later became intolerant to continuous positive airway pressure therapy, and her adherence to the related device decreased precipitously. The intolerance subsided gradually after a switch in medication to an angiotensin receptor blocker, and her adherence to continuous positive airway pressure device usage returned to baseline after 4 weeks. CITATION: Ou Y-H, Thant AT, Lee C-H. Sudden deterioration of CPAP adherence after myocardial infarction in a Chinese patient: potential effect of ACEI-induced airway hyperresponsiveness. J Clin Sleep Med. 2022;18(5):1463-1465.
© 2022 American Academy of Sleep Medicine.

Entities:  

Keywords:  adherence; airway; myocardial infarction; obstructive sleep apnea

Mesh：

Year:  2022        PMID： 35022127      PMCID： PMC9059603          DOI： 10.5664/jcsm.9880

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN： 1550-9389            Impact factor:   4.062


  10 in total

Review 1.  Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines.

Authors:  Peter V Dicpinigaitis
Journal:  Chest       Date:  2006-01       Impact factor: 9.410

2.  Angiotensin-converting enzyme inhibitors and obstructive sleep apnea.

Authors:  Alessandro Cicolin; Lucia Mangiardi; Roberto Mutani; Caterina Bucca
Journal:  Mayo Clin Proc       Date:  2006-01       Impact factor: 7.616

Review 3.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  J Am Coll Cardiol       Date:  2017-11-13       Impact factor: 24.094

4.  Prognostic implication of obstructive sleep apnea diagnosed by post-discharge sleep study in patients presenting with acute coronary syndrome.

Authors:  Germaine Loo; Adeline Y Tan; Chieh-Yang Koo; Bee-Choo Tai; Mark Richards; Chi-Hang Lee
Journal:  Sleep Med       Date:  2014-04-13       Impact factor: 3.492

5.  CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea.

Authors:  R Doug McEvoy; Nick A Antic; Emma Heeley; Yuanming Luo; Qiong Ou; Xilong Zhang; Olga Mediano; Rui Chen; Luciano F Drager; Zhihong Liu; Guofang Chen; Baoliang Du; Nigel McArdle; Sutapa Mukherjee; Manjari Tripathi; Laurent Billot; Qiang Li; Geraldo Lorenzi-Filho; Ferran Barbe; Susan Redline; Jiguang Wang; Hisatomi Arima; Bruce Neal; David P White; Ron R Grunstein; Nanshan Zhong; Craig S Anderson
Journal:  N Engl J Med       Date:  2016-08-28       Impact factor: 91.245

Review 6.  Angiotensin-converting enzyme inhibitor-induced angioedema.

Authors:  Shira Bezalel; Keren Mahlab-Guri; Ilan Asher; Ben Werner; Zev Moshe Sthoeger
Journal:  Am J Med       Date:  2014-07-21       Impact factor: 4.965

7.  High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese.

Authors:  K S Woo; M G Nicholls
Journal:  Br J Clin Pharmacol       Date:  1995-08       Impact factor: 4.335

8.  Effect of obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular events in patients with acute coronary syndrome (ISAACC study): a randomised controlled trial.

Authors:  Manuel Sánchez-de-la-Torre; Alicia Sánchez-de-la-Torre; Sandra Bertran; Jorge Abad; Joaquín Duran-Cantolla; Valentín Cabriada; Olga Mediano; María José Masdeu; Mari Luz Alonso; Juan Fernando Masa; Antonia Barceló; Mónica de la Peña; Mercè Mayos; Ramón Coloma; Josep M Montserrat; Eusebi Chiner; Salvador Perelló; Gemma Rubinós; Olga Mínguez; Lydia Pascual; Anunciación Cortijo; Dolores Martínez; Albina Aldomà; Mireia Dalmases; R Doug McEvoy; Ferran Barbé
Journal:  Lancet Respir Med       Date:  2019-12-12       Impact factor: 30.700

9.  Randomized clinical trials of cardiovascular disease in obstructive sleep apnea: understanding and overcoming bias.

Authors:  Allan I Pack; Ulysses J Magalang; Bhajan Singh; Samuel T Kuna; Brendan T Keenan; Greg Maislin
Journal:  Sleep       Date:  2021-02-12       Impact factor: 5.849

10.  SLCO1B1 Variants and Angiotensin Converting Enzyme Inhibitor (Enalapril)-Induced Cough: a Pharmacogenetic Study.

Authors:  Jian-Quan Luo; Fa-Zhong He; Zhen-Min Wang; Ning-Ling Sun; Lu-Yan Wang; Gen-Fu Tang; Mou-Ze Liu; Qing Li; Xiao-Ping Chen; Zhao-Qian Liu; Hong-Hao Zhou; Wei Zhang
Journal:  Sci Rep       Date:  2015-11-26       Impact factor: 4.379
  10 in total
  1 in total

1.  The interaction among OSA, CPAP, and medications in patients with comorbid OSA and cardiovascular/cerebrovascular disease: a randomized controlled trial.

Authors:  Miaochan Lao; Yilu Cheng; Xinglin Gao; Qiong Ou
Journal:  BMC Pulm Med       Date:  2022-03-21       Impact factor: 3.317
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.